Locations
Hingham, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Seed
founded in
2018
Sunflower Therapeutics is a biotechnology company founded in 2018, focused on delivering next-generation protein manufacturing solutions that are automated and fully integrated. Their key products include the Daisy Petal™ and Dahlia Petal™ perfusion bioreactor systems, which simplify the complex process of protein production, making it accessible to innovators in the biopharmaceutical and food industries. The company differentiates itself through its innovative perfusion fermentation method, which allows for continuous production and harvesting of proteins, leading to higher yields and healthier cell cultures. With a mission to increase access to biologics and vaccines, Sunflower Therapeutics is positioned to transform the protein manufacturing landscape, supported by significant grants and investments from organizations like the Bill & Melinda Gates Foundation and SK bioscience.
Something looks off?